| Intrinsic Valuation of: HBAN | |||||||||||
| Free Cash Flow Average and Growth over past 5Y | Key Statistics | ||||||||||
| Year | FCF | FCF (FCF/Revenue) | |||||||||
| 2020 | - | - | EPS (FY) | 1 | Market Cap | $31B | |||||
| 2021 | - | - (-) | P/E Ratio | 12 | Total Asset | $225B | |||||
| 2022 | $4B | - (-) | Net Income | $2B | Total Debt | $17B | |||||
| 2023 | $3B | -34.0% (-34.9%) | EBITDA | - | Total Liab | $201B | |||||
| 2024 | $2B | -32.7% (-33.0%) | Opr Margin | - | Debt/Equity | 0.71 | |||||
| 2025 | $2B | 30.8% (18.8%) | PreTax Margin | - | BV/Share | 7 | |||||
| 5Y Average FCF | $3B | 3.5% (-16.4%) | |||||||||
| Overall Market Assumptions: | |||||||||||
| Assumptions: | P/E for No-Growth Company: | 7.0 | |||||||||
| Perpetual Growth Rate (g): | 2.48% | Historical US Bond Yield: | 4.40% | ||||||||
| Discount Rate (WACC): | 9.09% | Current US Bond Yield: | 3.48% | ||||||||
| Forcasting Future Free Cash Flow for next 6Y | Modified Benjamin Graham's Intrinsic Value | ||||||||||
| Year | FCF Projection (3.5%) | ||||||||||
| 2026 | $2B | MBG Intrinsic Value | $12 | ||||||||
| 2027 | $2B | ||||||||||
| 2028 | $3B | ||||||||||
| 2029 | $3B | ||||||||||
| 2030 | $3B | ||||||||||
| 2031 | $3B | ||||||||||
| Terminal Value | $43B | Net Worth/Share | $12 | ||||||||
| DCF Valuation | DCF Valuation "What If" Scenario Table | ||||||||||
| Enterprise Value | $37B | Growth Rate | |||||||||
| (+) Cash & Cash Equivalents | $14B | $17 | 1.5% | 2.0% | 2.5% | 3.0% | 3.5% | ||||
| (-) Total Debt | $17B | WACC | 7.1% | 21 | 23 | 25 | 27 | 30 | |||
| Equity Value | $34B | 8.1% | 17 | 19 | 20 | 22 | 23 | ||||
| Shares Outstanding | 2,027,130,587 | 9.1% | 15 | 16 | 17 | 18 | 19 | ||||
| 10.1% | 13 | 14 | 14 | 15 | 16 | ||||||
| DCF Intrinsic Value | $17 | 11.1% | 11 | 12 | 12 | 13 | 14 | ||||
| Analyzed by QuantJuice (2025) | |||||||||||